Screen Shot 2019-10-21 at 3.22.59 pm
Wednesday, May 13, 2026
33.1
C
Bengaluru
Hot topics
Soft Power and the Physician
GST Special Issue carrying an interview with Sunil Attavar - CMD, Group Pharma and President, Karnataka Drugs and Pharmaceuticals Manufacturers Association (KDPMA)
India’s Booming OTC Pain Management Market: Trends, Growth & Consumer Behaviors
India’s Booming Pain Management Market: Trends, Growth & Consumer...
AI and the Future of Pharma Field Sales: Boon or Bane?
India’s pharmaceutical industry runs on the strength of its...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Hot topics
Indian Pharma Market October 2021 – IQVIA Report
IPM was valued at Rs. 178,219 Cr for MAT Oct’21. The retail sector was valued at Rs. 151,183 Cr for this period contributing 85% to IPM.
IPM Growth for the month of Oct’21 as compared to the month of Oct’20 was 9.7%. This is the lowest monthly growth in the last 8 months after a low growth of 2.6% reported for Feb’21.
Corresponding to low monthly growth, IPM MAT growth also declined slightly after showing a growing trend consistently for the last 7 months from MAT Feb’21. It reported 17.3% for MAT Oct’21 as compared to 17.8% reported for MAT Sept’21.
At 15657.3 Cr, the monthly sale reported for Oct’21 is the 5th highest sale value in the last 12 months.
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Dr. Peter Velev, CEO of CredoWeb discussing Digital in Pharma with MedicinMan
The digital revolution is the fourth industrial revolution. It changes models, processes and whole public sectors. In many reports you will find that, in terms of digitalization, pharma is just next to the public sector, as least digitalized. Pharma just started late. There are many reasons for that – it is one of the most regulated industries with lots of sensitive data involved and many ethical aspects. But the slowed down digitalization has a lot to do with some subjective reasons. Adopting digital technologies requires changing existing models which requires a different mindset – and this is difficult to achieve. Nowadays, in the situation of a global pandemic, we see that digital communication is not only necessary to be successful but it is a must in order to adapt to the New Normality.
Have Tech Advances Made UCPMP Obsolete? Need for Contemporary Pharma Marketing Code
Salil Kallianpur
The code of conduct for ethical pharmaceutical marketing...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Newsletter
Get important news delivered directly to your inbox and stay connected!